[Possibilities of enhancing the efficiency of therapy for purulent surgical infection].
Bulygin
G V
GV
Kamzalakova
N I
NI
Solonchuk
Iu R
IuR
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D008169:Lung Abscess / Q000188:drug therapy* / Q000276:immunology / Q000601:surgery; D009842:Oligopeptides / Q000627:therapeutic use*; D010538:Peritonitis / Q000188:drug therapy* / Q000276:immunology / Q000601:surgery; D013492:Suppuration / Q000188:drug therapy / Q000276:immunology / Q000601:surgery
D000900:Anti-Bacterial Agents; D009842:Oligopeptides; C462699:glutoxim